Earnings4503Astellas Pharma Inc.
Astellas Pharma Q1 FY2027 Earnings Presentation: Revenue of 640 billion, +26.7% YoY
TOKYO, Aug 05 (Pulse News Wire) – Astellas Pharma Inc. (4503.T) released its earnings presentation for Q1 FY2027.
Revenue was ¥640 billion (+26.7% YoY). Operating profit was ¥220 billion.
Total assets stood at ¥3.7 trillion.
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥640,914M | +26.7% |
| Operating profit | ¥184,506M | +94.9% |
| Net profit | ¥141,752M | +107.2% |
Next period forecast
Revenue
¥2,220,000M
+3.8%Op. profit
¥395,000M
+3.2%Net profit
¥300,000M
+2.9%Figures in millions of yen
End of article